David M. Stack, CEO and Chairman at Pacira BioSciences, Inc. (PCRX), sold 51,085 shares at $61.37 ($3.1M) on 2022-06-06, disclosed to the SEC on 2022-06-08.
Seasonal sale ($3.1M) by CEO and Chairman — this insider has traded PCRX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.37 | 11,965 | $734K | 23.7% |
| 2 | $61.37 | 11,965 | $734K | 23.7% |
| 3 | $59.10 | 7,039 | $416K | 13.5% |
| 4 | $59.10 | 7,039 | $416K | 13.5% |
| 5 | $60.33 | 5,006 | $302K | 9.8% |
| 6 | $60.33 | 5,006 |
| $302K |
| 9.8% |
| 7 | $61.31 | 1,282 | $79K | 2.5% |
| 8 | $61.31 | 1,282 | $79K | 2.5% |
| 9 | $61.96 | 501 | $31K | 1.0% |
| Total | $60.54 avg | 51,085 | $3.1M | 100% |
| Filing → |
| AMRN | BUY | 2021-06-07 | $69K | — | Filing → |
| PCRX | SELL | 2021-05-13 | $5.2M | — | Filing → |
| PCRX | SELL | 2021-02-04 | $4.0M | — | Filing → |